The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B

10.1016/j.jhealeco.2023.102754

Saved in:

Bibliographic Details
Main Author:	Han, Dan
Other Authors:	DEAN'S OFFICE (LKY SCH OF PUBLIC POLICY)
Format:	Article
Language:	English
Published:	ELSEVIER 2023
Subjects:	Social Sciences Science & Technology Life Sciences & Biomedicine Economics Health Care Sciences & Services Health Policy & Services Business & Economics 340B Drug Pricing Critical Access Hospitals Cost-based reimbursement Medicare CONSEQUENCES CARE
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/242537
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-242537
record_format	dspace
spelling	sg-nus-scholar.10635-2425372023-10-30T23:11:10Z The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B Han, Dan DEAN'S OFFICE (LKY SCH OF PUBLIC POLICY) Social Sciences Science & Technology Life Sciences & Biomedicine Economics Health Care Sciences & Services Health Policy & Services Business & Economics 340B Drug Pricing Critical Access Hospitals Cost-based reimbursement Medicare CONSEQUENCES CARE 10.1016/j.jhealeco.2023.102754 JOURNAL OF HEALTH ECONOMICS 89 2023-06-27T00:47:21Z 2023-06-27T00:47:21Z 2023-05 2023-06-26T13:36:27Z Article Han, Dan (2023-05). The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B. JOURNAL OF HEALTH ECONOMICS 89. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jhealeco.2023.102754 0167-6296 1879-1646 https://scholarbank.nus.edu.sg/handle/10635/242537 en ELSEVIER Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Social Sciences Science & Technology Life Sciences & Biomedicine Economics Health Care Sciences & Services Health Policy & Services Business & Economics 340B Drug Pricing Critical Access Hospitals Cost-based reimbursement Medicare CONSEQUENCES CARE
spellingShingle	Social Sciences Science & Technology Life Sciences & Biomedicine Economics Health Care Sciences & Services Health Policy & Services Business & Economics 340B Drug Pricing Critical Access Hospitals Cost-based reimbursement Medicare CONSEQUENCES CARE Han, Dan The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
description	10.1016/j.jhealeco.2023.102754
author2	DEAN'S OFFICE (LKY SCH OF PUBLIC POLICY)
author_facet	DEAN'S OFFICE (LKY SCH OF PUBLIC POLICY) Han, Dan
format	Article
author	Han, Dan
author_sort	Han, Dan
title	The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
title_short	The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
title_full	The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
title_fullStr	The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
title_full_unstemmed	The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
title_sort	impact of the 340b drug pricing program on critical access hospitals: evidence from medicare part b
publisher	ELSEVIER
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/242537
_version_	1781793535544000512

The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B

Similar Items